LEAH Labs
Engineering living therapies for pets and their people
LEAH Labs is building a discovery engine for cell therapy development using virus-free gene editing technology, with dogs and cancer as a beachhead market. Dogs and humans get the same types of diseases, especially cancers, and are great models for one another. Our company is the first to bring CAR-T cell therapy to pets as both an unmet need for companion animal medicine, but also as a platform to discover and de-risk potential human assets. We operate under USDA jurisdiction, a regulatory environment prime for innovation that is orders of magnitude more cost effective to iterate within than FDA.
Active Founders
Wesley Wierson
I am a scientist and entrepreneur seeking to apply my expertise in gene editing towards solving consumer level problems in society. I believe that gene editing technology has the power to rewrite human history, and it is paramount that scientists apply gene editing with precise control over the outcomes, both at the molecular and the societal impact levels. I am building LEAH Labs, an animal health startup focused on using gene editing to bring cell therapies to veterinary medicine.
